|
|
Volumn 333, Issue , 2001, Pages 306-318
|
|
Orally bioavailable farnesyltransferase inhibitors as anticancer agents in transgenic and xenograft models
a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (8 CHLORO 5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE) 1 (4 PYRIDYLACETYL)PIPERIDINE;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
CYTOTOXIC AGENT;
FLUOROURACIL;
LONAFARNIB;
PACLITAXEL;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
VINCRISTINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
CELL PROLIFERATION;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INHIBITION;
DRUG STABILITY;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MONKEY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
REVIEW;
TRANSGENIC MOUSE;
TUMOR XENOGRAFT;
ANIMALIA;
MUS MUSCULUS;
|
|
EID: 0034993869
PISSN: 00766879
EISSN: None
Source Type: Book Series
DOI: 10.1016/S0076-6879(01)33065-3 Document Type: Article |
|
Times cited : (4)
|
|
References (17)
|
